New Zealand markets closed

Matinas BioPharma Holdings, Inc. (MTNB)

NYSE American - NYSE American Delayed price. Currency in USD
Add to watchlist
0.1561+0.0061 (+4.07%)
At close: 04:00PM EDT
0.1590 +0.00 (+1.86%)
After hours: 07:39PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-24,062
-22,942
-20,997
-23,283
-22,447
-
Depreciation & amortisation
877.286
941
898
781
774.587
-
Deferred income taxes
-
-
-
-
-
0
Stock-based compensation
4,963
4,948
5,228
4,292
4,565
-
Change in working capital
-1,121
1,667
-4,789
1,535
-508.688
-
Accounts payable
-5.281
-103
-321
588
-329.369
-
Other working capital
-19,701
-15,496
-20,048
-15,483
-17,374
-
Other non-cash items
526.98
107
502
1,450
239.831
-
Net cash provided by operating activities
-18,814
-15,278
-19,156
-15,223
-17,368
-
Cash flows from investing activities
Investments in property, plant and equipment
-886.591
-218
-892
-260
-5.749
-
Purchases of investments
-14,888
0
-9,481
-23,195
-72,106
-
Sales/maturities of investments
20,750
13,460
15,250
40,225
31,445
-
Net cash used for investing activities
4,976
13,242
4,877
16,770
-40,667
-
Cash flows from financing activities
Debt repayment
-22.194
-7
-20
-30
-54.673
-
Common stock issued
0
-
0
5,580
46,704
30,103
Net cash used provided by (used for) financing activities
91.731
-7
79
6,965
48,047
-
Net change in cash
-13,747
-2,043
-14,200
8,512
-9,988
-
Cash at beginning of period
25,173
7,080
21,280
12,768
22,756
-
Cash at end of period
11,426
5,037
7,080
21,280
12,768
-
Free cash flow
Operating cash flow
-18,814
-15,278
-19,156
-15,223
-17,368
-
Capital expenditure
-886.591
-218
-892
-260
-5.749
-
Free cash flow
-19,701
-15,496
-20,048
-15,483
-17,374
-